Evidence map›Paper›PMID 31181813›Full record

ArticleCancers2019

The

Simona Pellecchia, Romina Sepe, Antonella Federico, Mariella Cuomo, Sara Carmela Credendino, Pasquale Pisapia, Claudio Bellevicine, Pedro Nicolau-Neto, Mariana Severo Ramundo, Elvira Crescenzi and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. BioMark: biomarker analysis tool.BMC bioinformatics · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Characterization ofCell cycle (Georgetown, Tex.) · 2020
    Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Simona PellecchiaInstitute for Experimental Endocrinology and Oncology (IEOS) "G. Salvatore", National Research Council (CNR), Via Sergio Pansini 5, 80131 Naples, Italy. simona.pellecchia@gmail.com.ORCID 0000-0001-6826-8407
Romina SepeInstitute for Experimental Endocrinology and Oncology (IEOS) "G. Salvatore", National Research Council (CNR), Via Sergio Pansini 5, 80131 Naples, Italy. romina.sepe@unina.it.ORCID 0000-0001-7162-7706
Antonella FedericoInstitute for Experimental Endocrinology and Oncology (IEOS) "G. Salvatore", National Research Council (CNR), Via Sergio Pansini 5, 80131 Naples, Italy. anfederi@unina.it.
Mariella CuomoInstitute for Experimental Endocrinology and Oncology (IEOS) "G. Salvatore", National Research Council (CNR), Via Sergio Pansini 5, 80131 Naples, Italy. cuomomariella.91@gmail.com.
Sara Carmela CredendinoDepartment of Molecular Medicine and Medical Biotechnology (DMMBM), University of Naples "Federico II", Via Sergio Pansini 5, 80131 Naples, Italy. credendinosara@gmail.com.
Pasquale PisapiaDepartment of Public Health, University of Naples "Federico II", Via Sergio Pansini 5, 80131 Naples, Italy. pasqualepisapia89@gmail.com.ORCID 0000-0002-6429-0620
Claudio BellevicineDepartment of Public Health, University of Naples "Federico II", Via Sergio Pansini 5, 80131 Naples, Italy. claudiobellevicine@gmail.com.
Pedro Nicolau-NetoInstituto Nacional de Cancer, 37908, Laboratorio de Carcinogênese Molecular, Rua Andre Cavalcanti 37, Centro, Rio de Janeiro 20231-050, Brazil. pedronicolau.n@gmail.com.ORCID 0000-0003-3322-2120
Mariana Severo RamundoInstituto Nacional de Cancer, 37908, Laboratorio de Carcinogênese Molecular, Rua Andre Cavalcanti 37, Centro, Rio de Janeiro 20231-050, Brazil. marianasevero@gmail.com.
Elvira CrescenziInstitute for Experimental Endocrinology and Oncology (IEOS) "G. Salvatore", National Research Council (CNR), Via Sergio Pansini 5, 80131 Naples, Italy. e.crescenzi@ieos.cnr.it.
Gabriella De VitaDepartment of Molecular Medicine and Medical Biotechnology (DMMBM), University of Naples "Federico II", Via Sergio Pansini 5, 80131 Naples, Italy. gdevita@unina.it.ORCID 0000-0002-7302-1174
Luigi Maria TerraccianoInstitute of Pathology, Molecular Pathology Division, University of Basel, Schönbeinstrasse 40, 4031 Basel, Switzerland. luigi.terracciano@usb.ch.
Lorenzo ChiariottiInstitute for Experimental Endocrinology and Oncology (IEOS) "G. Salvatore", National Research Council (CNR), Via Sergio Pansini 5, 80131 Naples, Italy. chiariot@me.com.
Alfredo FuscoInstitute for Experimental Endocrinology and Oncology (IEOS) "G. Salvatore", National Research Council (CNR), Via Sergio Pansini 5, 80131 Naples, Italy. alfusco@unina.it.
Pierlorenzo PallanteInstitute for Experimental Endocrinology and Oncology (IEOS) "G. Salvatore", National Research Council (CNR), Via Sergio Pansini 5, 80131 Naples, Italy. pallante@ieos.cnr.it.ORCID 0000-0001-7319-684X
Institute for Experimental Endocrinology and Oncology · ITUniversity of Naples Federico II · ITInstituto Nacional de Câncer - INCA · BRUniversity of Basel · CH

Funding

PNR-CNR Aging Program 2012-2014, CNR Flagship Projects (Epigenomics-EPIGEN), Associazione Italiana per la Ricerca sul Cancro (AIRC IG 11477)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast cancerlong non-coding RNAmethylationMPPED2MPPED2-AS1tumor suppressor

Identifiers

PMID31181813
PMCPMC6627064
OpenAlexW2948662335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.